Abstract
This study highlights the prognostic impact of FOXP3 and CD68 expression in DLBCL, NOS and in its GCB and non-GCB subtypes. This may help the development of individualized therapy, prognostic prediction and therapy stratification.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have